News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
The search for a cure
Reviewing Strategies for Draining HIV Reservoirs

The April issue of Human Vaccines & Immunotherapeutics features an excellent open access review by Thomas Rasmussen and colleagues describing approaches to eliminating HIV reservoirs that are advancing into clinical trials.

Published
01 May 2013
From
Treatment Action Group
Pharmaceutical industry
Johnson & Johnson allies with biotech startup on HIV drug in China

The biopharma startup Ascletis has snagged exclusive rights from Johnson & Johnson's ($JNJ) Janssen for an experimental HIV protease inhibitor for the China market. Hangzhou, China-based Ascletis aims to develop the candidate, called TMC310911.

Published
01 May 2013
From
FierceBiotech
New and experimental HIV treatments
FDA rejects two of the four drugs in Gilead's blockbuster HIV drug Stribild

The FDA has handed back a pair of new drug applications from Gilead ($GILD) covering key products used in its blockbuster four-in-one HIV-fighting therapy Stribild.

Published
30 April 2013
From
FierceBiotech
The search for a cure
‘Cured of AIDS’? Not Yet

What to make of all the recent “cured of AIDS” headlines? An American in Berlin, a baby in Mississippi and 14 patients in France are all alive without treatment. Is a cure at hand? No. But in unusual cases, some people seem able, with temporary help from antiretroviral drugs, to kill the virus before it can sink into reservoirs deep in their bodies — or to at least force it to stand at the doorways of their cells, unable to get in.

Published
30 April 2013
From
New York Times
The search for a cure
Scientists on brink of HIV cure

Researchers believe that there will be a breakthrough in finding a cure for HIV “within months”.

Published
28 April 2013
From
Sunday Telegraph
Vaccines
Researchers stop the only current HIV vaccine efficacy trial

The US National Institute of Allergy and Infectious Diseases (NIAID) has announced that it is discontinuing the HVTN 505 HIV vaccine trial. This trial, which started in July

Published
26 April 2013
By
Gus Cairns
Pharmaceutical industry
Europe: Medicines under additional monitoring

The European Medicines Agency has published today the initial list of medicines under additional monitoring. These medicines are being monitored even more intensively than other medicines. This is generally because there is less information available on it than on other medicines, for example because it is new to the market or there is limited data on its long-term use. It does not mean that the medicine is unsafe.

Published
26 April 2013
From
European Medicines Agency
Experiences of stigma
South Africa: 'He said sex with a virgin could cure HIV'

A Soweto man allegedly raped his two-year-old daughter, believing it would cure him of HIV. This chilling evidence is part of a police investigation into the rape of the child on February 3.

Published
26 April 2013
From
Independent Online
Treatment guidelines
AIDS Healthcare Foundation Applauds WHO Decision to Initiate HIV Treatment Earlier

World Health Organization (WHO) announced this week at Treatment as Prevention conference in Vancouver, Canada, that it will raise treatment initiation guidelines for HIV-positive individuals from a CD4 count of less than 350 to a count of less than 500.

Published
25 April 2013
From
Wall Street Journal
The search for a cure
Doctors' historic effort to cure child with HIV and leukemia

A University of Minnesota team performed an unprecedented transplant on Tuesday in an effort to cure a 12-year-old boy who has both HIV and leukemia. Their potential solution: umbilical cord blood containing a protein known to protect a person against HIV.

Published
25 April 2013
From
MPR News
← Prev12345...312Next →

Filter by country